Prot # CSOM230CUS33: An Acromegaly, Open-label, Multi-Center, Safety Monitoring Program for Treating Patients with SOM230 (Pasireotide) LAR Who Have Need to Receive Medical Therapy (ACCESS)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/21/1412/31/15

Funding

  • Novartis Pharmaceuticals Corporation (CSOM230BUS33)